Global Menopause Drug Market Size study, by Stages Type (Perimenopause, Menopause, Post menopause) by Treatment Type (Non-Hormonal Treatment, Hormonal Treatment, Herbal Supplements) by Product Type (Patch, Pill, Gel, Injectable, Cream, Others) by Route of

Global Menopause Drug Market Size study, by Stages Type (Perimenopause, Menopause, Post menopause) by Treatment Type (Non-Hormonal Treatment, Hormonal Treatment, Herbal Supplements) by Product Type (Patch, Pill, Gel, Injectable, Cream, Others) by Route of Administration Types (Oral, Injectable, Topical) by End-Users (Hospitals, Homecare, Specialty Clinics, Others) and Regional Forecasts 2022-2028

Global Menopause Drug Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. (Mar) Menopause Drug is a type of walk-in clinic that provides ambulatory care in a dedicated medical facility outside of a conventional emergency room (ER). Also, the Menopause Drug is used for treating injuries and illness that need immediate care. The increase in percentage of women aged 40-65 years impacted them the most has led the adoption of Menopause Drug across the forecast period. According to a survey conducted in 2021 by Statista, 1 in 6 women aged 40 to 65 claimed hot flashes were the most bothersome symptom of menopause. Another 15% experienced weight increase, with vaginal dryness and uncomfortable sex affecting the majority of women (12%). As of 2021, this statistic shows the percentage of women aged 40 to 65 in the United States who reported that menopause symptoms affected them the most. Also, with the increasing research and development in the drugs, the adoption & demand for Menopause Drug is likely to increase the market growth during the forecast period. However, low awareness regarding this drug impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Menopause Drug Market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the significant region across the world in terms of market share owing to the high prevalence of unhealthy lifestyle and rising introduction of novel drugs in this region. Whereas, Asia-Pacific is anticipated to exhibit highest CAGR over the forecast period 2022-2028. Factors such as increase in the vulnerable aging population of menopause women and increase in the demand of novel therapies would create lucrative growth prospects for the Menopause Drug Market across Asia-Pacific region.

Major market player included in this report are:
Teva Pharmaceutical Industries Ltd.
Eli Lilly and Company
Cipla Inc
Allergan
Pfizer, Inc
Novo Nordisk A/S
Novartis AG
Merck & Co., Inc
Emcure
Viramal,
EuroPharma USA

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Stages Type:
Perimenopause
Menopause
Post menopause
By Treatment Type:
Non-Hormonal Treatment
Hormonal Treatment
Herbal Supplements
By Product Type:
Patch
Pill
Gel
Injectable
Cream
Others
By Route of Administration Type:
Oral
Injectable
Topical
By End Users:
Hospitals
Homecare
Specialty Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Menopause Drug Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Teva Pharmaceutical Industries Ltd.
Eli Lilly and Company
Cipla Inc
Allergan
Pfizer, Inc
Novo Nordisk A/S
Novartis AG
Merck & Co., Inc
Emcure
Viramal,
EuroPharma USA

Please note: The single user license is non-downloadable and non-printable. Global Site license allows these actions.